United States · FDA National Drug Code directory

BUPROPION HYDROCHLORIDE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71205-504_8ab86beb-3616-414c-92bf-25273a853a9e
Product NDC
71205-504
Form
TABLET, EXTENDED RELEASE
Composition / generic term
BUPROPION HYDROCHLORIDE
Labeler
Proficient Rx LP
Marketing category
ANDA
Marketing start / end (source format)
20181108
Source listing expiry
20261231

Source-listed ingredients

  • BUPROPION HYDROCHLORIDE — 150 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-504-30) · 71205-504-30
  • 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-504-60) · 71205-504-60
  • 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-504-90) · 71205-504-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →